TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 148 filers reported holding TG THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,808,350 | -35.6% | 270,284 | -45.0% | 0.03% | -38.0% |
Q1 2024 | $7,469,599 | +29.7% | 491,098 | +45.7% | 0.05% | +31.6% |
Q4 2023 | $5,758,504 | -49.6% | 337,149 | -75.3% | 0.04% | -57.3% |
Q3 2023 | $11,431,464 | -11.0% | 1,367,400 | +164.5% | 0.09% | -19.1% |
Q2 2023 | $12,839,622 | -19.9% | 516,893 | -51.5% | 0.11% | -28.1% |
Q1 2023 | $16,020,803 | +2049.6% | 1,065,213 | +1590.8% | 0.15% | +2450.0% |
Q4 2022 | $745,290 | +219.9% | 63,000 | +60.1% | 0.01% | +200.0% |
Q3 2022 | $233,000 | -87.4% | 39,348 | -91.0% | 0.00% | -88.9% |
Q2 2022 | $1,854,000 | +51.5% | 436,331 | +1753.8% | 0.02% | +12.5% |
Q4 2020 | $1,224,000 | -29.4% | 23,537 | -73.5% | 0.02% | -30.4% |
Q2 2020 | $1,734,000 | +729.7% | 88,958 | +319.3% | 0.02% | +76.9% |
Q1 2020 | $209,000 | -55.7% | 21,218 | -36.2% | 0.01% | -62.9% |
Q1 2018 | $472,000 | – | 33,277 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |